ANCN - Anchiano Therapeutics Ltd - ADR
Previous close
75.36
0 0%
Share volume: 0
Last Updated: Tue 16 Mar 2021 05:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$75.36
0.00
0.00%
Summary score
37%
Profitability
41%
Dept financing
11%
Liquidity
33%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-118.52%
Return on assets
-42.29%
Return on sales
0%
Return on invested capital
307.7%
Total debt ratio
73.89%
Debt ratio change over timeo
-0.01%
Current Ratio
3%
Quick Ratio
0%
Cash Position Ratio
2.17%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-46.35%
Return on assets
-24.03%
Return on sales
0%
Return on invested capital
49.06%
Total debt ratio
34.21%
Debt ratio change over timeo
-0.94%
Current Ratio
3.94%
Quick Ratio
0%
Cash Position Ratio
3.72%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-43.07%
Return on assets
-35.1%
Return on sales
0%
Return on invested capital
249.71%
Total debt ratio
18.56%
Debt ratio change over time
-0.84%
Current Ratio
5.52%
Quick Ratio
0%
Cash Position Ratio
5.04%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-324.71%
Return on assets
-149.64%
Return on sales
0%
Return on invested capital
-29.57%
Total debt ratio
-0.85%
Debt ratio change over time
-0.01%
Current Ratio
0.66%
Quick Ratio
0%
Cash Position Ratio
0.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ANCN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -118.52% | 0% | 0% | 29.06% |
| Return on assets | -42.29% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 307.7% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 29% |
| Total debt ratio | 73.89% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.01% | 0% | 0% | 19.02% |
| Dept financing | 10% | 0% | 0% | 50% |
| Current Ratio | 3.94% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 3.72% | 0% | 0% | 5.68% |
| Liquididy | 33% | 0% | 0% | 75% |
| Short-term ratios | ANCN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -46.35% | 0% | 0% | -16.12% |
| Return on assets | -24.03% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 49.06% | 0% | 0% | 96.56% |
| Profitability | 38% | 0% | 50% | 25% |
| Total debt ratio | 34.21% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.94% | 0% | 0% | 0.09% |
| Dept financing | 11% | 0% | 0% | 50% |
| Current Ratio | 3.94% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 3.72% | 0% | 0% | 5.68% |
| Liquididy | 33% | 0% | 0% | 75% |